Documente Academic
Documente Profesional
Documente Cultură
th
0800-0900
ESC@APSC Paediatric KLlive ESC@APSC MYLIVE/7 AICT
( Live Transmission)
th
0900-1000
ESC@APSC Paediatric KLlive ESC@APSC MYLIVE/7 AICT
( Live Transmission)
th
1000-1100
1100-1200
ESC@APSC
1200-1300
1500-1600
1600-1700
ESC@APSC
1700-1800
1800-1900
1900-2000
Paediatric KLlive EURO PCR@APSC Satellite Lunch Symposium 1 Satellite Lunch Symposium 2 Satellite Lunch Symposium 3 MYLIVE/7 AICT
( Live Transmission)
th
Paediatric KLlive Special Lecture 1 (S1) Satellite Lunch Symposium 4 Satellite Lunch Symposium 5 Satellite Lunch Symposium 6 Satellite Lunch Symposium 7 Satellite Lunch Symposium 8 MYLIVE/7 AICT
( Live Transmission)
th
Cardiac Imaging (HT1) Preventive Cardiology 6 (HT5) Endovascular Therapeutics (HT3) Interventional Cardiology (HT4) Arrhythmia (HT2) Hypertension (HT6) Interventional Cardiology (HT7) HT10 Cardiac Imaging (HT8) Preventive Cardiology7 (HT12) Clinical Cardiology 1 (HT11)
MYLIVE/7th AICT Cardiac Imaging 2 (S4) Myocardial Ischaemia 1 (S5) Preventive Cardiology 1(S6)
MYLIVE/7th AICT Joint Symposium 5 (S46) - SPAF Cardiac Rehab 1 (S8) Valvular Heart Disease 1 (S9)
Satellite Symposium 3 Satellite Symposium 4 Satellite Symposium 5 Satellite Symposium 6 Satellite Symposium 7
Paediatric Cardiology 2 Heart Failure 3 (S17) Congenital Cardiology 1 (S35) Women and Heart Disease 1 Endovascular Therapeutics 1 (S19)
TEA BREAK
Paediatric Cardiology 3 Heart Failure 4 (S22) General Cardiology 1 (S24) Women and Heart Disease 2 Joint Symposium 1 (S20) Cardiac Rehab 2 (S15) Clinical Cardiology 2 (S21) Satellite Lunch Symposium 9 Satellite Lunch Symposium 10 Satellite Lunch Symposium 11
Paediatric Cardiology 4 Meet the Experts 1 (S27) Joint Symposium 2 (S26) Women and Heart Disease 3 Cardiac Surgery 1 (S28) Hypertension 4 (S25) Preventive Cardiology 2 (S29)
Paediatric Cardiology 5 Vascular Disease 1 (S32) ACLS (S31) Women and Heart Disease 4 Cardiac Imaging 3 (S30) Cardiac Rehab 3 (S33) Joint Symposium 3 (S34)
PT BH B1 B2
Preventive Cardiology 3 (P7) Arrhythmia 2 (P8) Cardiac Imaging 3 (S40) Joint Symposium 4 (S43) Preventive Cardiology 4 (S44)
Chairpersons: ESC1-1 My ESC in Malaysia - Highlights of ESC Congresses 2010-2011. M Komajda (Paris,FR) ESC1-2 ESC Congress. R Ferrari (Ferrara,IT) ESC1-3 Euroecho. F J Pinto (Lisbon,PT) ESC1-4 EuroPRevent. D A Wood (London,GB)
11:00 - 12:30
Chairpersons: ESC2-1 ECG's of small complex tachycardia T C Gillebert (Gent,BE) ESC2-2 Comments/Q&A. Surinder ESC2-3 A patient with elevated cholesterol and triglycerides. D A Wood (London,GB) ESC2-4 Comments/Q&A. Hirotsugu Ueshima ESC2-5 A patient with syncope. M Duytschaever (Gent,BE) ESC2-6 Comments/Q&A. Ajay Naik /Imran
12:30 14:00
A LEAP FORWARD IN THE MANAGEMENT OF CORONARY PATIENT UPDATE FOR THE 1ST IF INHIBITOR IVABRADINE SATELITE SYMPOSIUM ORGANISE BY SERVIER
12:30 - 12:40
12:40 13:05
Ivabradine, a breakthrough for pure heart rate reduction in the treatment of stable angina Roberto Ferrari
13:05 13:35
New insights of heart failure, the SHIFT study with ivabradine Michel Komajda
13:35 13:50
13:50
14:00 - 15:30
ESC GUIDELINES I
Chairpersons: ESC3-1 I- Management of patients with atrial fibrillation. M Duytschaever (Gent,BE) ESC3-2 Comments/Q&A. Narasimhan (India) / Razali ESC3-3 II- CRT/ICD in heart failure. K Dickstein (Stavanger,NO) ESC3-4 Comments/Q&A. Azlan Hussin
16:00 - 17:30
ASSESSMENT OF DYSSYNCHRONY
Chairpersons: ESC4-1 The view of the physiologist. T C Gillebert (Gent,BE) ESC4-2 The view of the echocardiologist. F J Pinto (Lisbon,PT) ESC4-3 The view of the electrophysiologist. M Duytschaever (Gent,BE) ESC4-4 The view of the heart failure doctor K Dickstein (Stavanger,NO) ESC4-5 Q&A. NEW ERA IN STROKE PREVENTION FOR ATRIAL FIBRILLATION PATIENTS WITH NOVEL ORAL ANTICOAGULANTS SATELLITE SYMPOSIUM ORGANISED BY BAYER HEALTH CARE
17:30 19:00
Chairperson: David Quek (Malaysia) 17:30 17:35 17:35 17:55 17:55 18:10 18:10 18:35 18:35 18:55 18:55 19:00
Welcome & Introduction David Quek (Malaysia) Assessing stroke risk in Atrial Fibrillation: Focus on the new European, Canadian and American Atrial Fibrillation management guidelines Gregory Y H Lip (UK) Anticoagulation issues and management options Sim Kui Hian (Malaysia) Role of Direct Factor Xa Inhibition for Stroke Prevention in Atrial Fibrillation Clinical implications of ROCKET AF study John Paolini (USA) Case Based Discussions Antithrombotic therapy in AF Tan Ru San (Singapore) Discussion & Summary David Quek (Malaysia)
How to close PDAs with unusual anatomy (10 min) Neil Wilson (United Kingdom)
Case 3-Coarctation
Stent preparation, loading and delivery step by step (10 min) Neil Wilson (UK)
Case 4-PAVM
How to deal with stent complications (10 min) Shakeel A. Qureshi (UK)
ASD - Assessing suitability for device closure (10 min) Geoff Lane (Australia)
How to close large ASDs (10 min) Jae Young Choi (Korea)
Case 8 PDA
Hybrid 2 MusVSD, MR
09:30 - 10:30
Chairpersons: ESC6-1 Unexplained fever. F J Pinto (Lisbon,PT) ESC6-2 Comments/Q&A. Lam Kai Huat ESC6-3 A case of stable angina pectoris. F Van de Werf (Leuven,BE) ESC6-4 Comments/Q&A. Chee Kok Han
11:00 - 12:30
Chairpersons: ESC7-1 A case of Acute Coronary Syndrome R Ferrari (Ferrara,IT) ESC7-2 Comments/Q&A. Seyyed Tabatabaei ESC7-3 A case of resistant heart failure. K Dickstein (Stavanger,NO) ESC7-4 Comments/Q&A. TBC
ESC7-5
ESC7-6
ESC7-7
16:00 17:30 Chairpersons: EC-10 Solve the Echo Puzzle Interesting cases
10:30 12:30 Case 11 MAPCAs Hybrid intervention - assessment of muscular VSD and device selection (12 min). Highlight apical VSD with no apical rim Ziyad M. Hijazi (US) Post infarct VSD assessment, timing and technique of closure (12 min). Stress on assessment and case selection Joseph De Giovanni (UK) Hybrid 3 Per-Ventricular VSD 14:30 15:30 Case 13 Paravalvular leak or Coarctation Paravalvular leaks 1. 2. Kiv Hybrid 4 PA stenting 16:00 17:30 Case 15 PDA stenting Fistulas, collaterals and abnormal vessels 1. 2. 3. Occlusive devices what are available Geoffrey Lane (Australia) (10 min) How to close CAF Shakeel A Qureshi (UK)(12min) How to close veno-veno collaterals & MAPCAs Kritvitkrom Durongpisitkul (Thailanad) (10 min) How to assess by TEE Joseph Vettukatil (KIV) How to close Joseph De Giovani (United Kingdom) (12 min)
Chairpersons: Dr. Sim Kui Hian/Dr. Akira Matsumori P1-1 Post AMI remodelling: mechanism of action Roberto Ferrari (Italy) P1-2 Heart Failure with preserved EF Michel Komadja (France)
SYMPOSIUM 7
09:00 10:30 HEART FAILURE 2: PREVENTING PROGRESSION TO HEART FAILURE Chairpersons: S7-1 Post MI and Asymptomatic LV Dysfunction to Heart Failure Frans Van de Werf S7-2 Coronary Artery Disease and Dyslipidemia to Heart Failure Zurkarnai (HUSM) S7-3 Hypertension, Left Ventricular Hypertrophy and Diastolic Dysfunction Thierry Gillebert
SYMPOSIUM 47
11:00 12:30 JOINT SYMPOSIUM 6 - CSC@APSC2011: QUALITY CARE INITIATIVE IN CARDIOVASCULAR DISEASE
Chairpersons: Hu Dayi/ Alan Fong (Malaysia) S47-1 Targeted case finding for cardiovascular prevention Prof Zhao Dong S47-2 Clinical pathway in the care of ACS patients in China Prof Gao Runlin Candidate: Prof Wu Yangfeng, Prof Du Xin Improving facilities for STEMI patients receiving reperfusion therapy Prof Huo Yong Performance improvement in the care of atrial fibrillation patients Prof Ma Changsheng Discussion
S47-3
S47-4
S47-5
SYMPOSIUM 1
14:00 15:30 SPECIAL LECTURE 1: HYBRID PROCEDURE Chairpersons: Dr. Ryuji Nohari/Dato Anuar Masduki S1-1 Design of Hybrid Catherization Lab, Keys to Success Ralf Holzer (USA) S1-2 Obtaining the Best of the Two Worlds - Cardiologist Perspective Tan Huay Cheem (Singapore) S1-3 Hybrid Coronary Revascularization - The Heart Surgeon's Perspective Azhari Yaacob (Malaysia)
HOW TO SESSION 5
17:30 18:30 PREVENTIVE CARDIOLOGY 6: HOW TO EFFECTIVELY MANAGE ASIAN DIABETICS
HT5-1
HT5-2
How to Prevent and Delay Diabetic Renal Disease Paola Fioretto (Italy)
HT5-3
Chairpersons: Prof. Sim & Greg Thomas P3-1 Echocardiography Fausto Pinto (Portugal) P3-2 Cardiac MR Eike Nagel (Germany) P3-3 Cardiac CT SCCT speaker-Samuel Wann(Prof Sim /Dr TK Ong To confirmed) P3-4 Nuclear Cardiology Gregory Thomas (USA)
SYMPOSIUM 2
09:00 10:30 ARRHYTHMIA 1: ATRIAL FIBRILLATION Chairpersons: Balbir Singh (India) / Razali S2-1 Beyond Rate and Rhythm Control Gregory Lip (United Kingdom) S2-2 Catheter Ablation for AF Defining the strategy Teo Wee Siong (Singapore) S2-3 Anticoagulation Strategies: Old and New Gregory Lip (United Kingdom)
SYMPOSIUM 4
11:00 12:30 Chairpersons: S4-1 CMR in Management of Chest Pain Stephen Harden (United Kingdom) S4-2 Role of CMR in Managing Patients with Known Coronary Artery Disease Annuar Rapaee (Malaysia) S4-3 Coronary MRA: Current Status And Future Perspective Eike Nagel (Germany) CARDIAC IMAGING 2: WHERE CMR MAKES A DIFFERENCE IN THE MANAGEMENT OF CORONARY ARTERY DISEASE
BAYER SATELLITE LUNCH SYMPOSIUM 12:30 12:35 12:35 12:55 12:55 13:10 13:10 13:35 13:35 13:50 13:50 14:00 Welcome & Introduction Sim Kui Hian (Malaysia) Stroke Prevention in Atrial Fibrillation (SPAF) Key issues for effective management, with focus on the Asia-Pacific region Gregory Y H Lip (UK) Clinical Review- oral anticoagulants in SPAF management Tan Ru San (Singapore) Moving closer to a more successful SPAF management with Rivaroxaban John Paolini (USA) Case Based Discussions new oral anticoagulant therapy in AF Tan Ru San (Singapore) Discussion & Summary Sim Kui Hian (Malaysia)
SYMPOSIUM 46
14:00 15:30 JOINT SYMPOSIUM 5: STROKE PREVENTION IN ATRIAL FIBRILLATION A CALL TO ACTION: FOCUS ON THE ASIA-PACIFIC REGION
Chairpersons: Sim Kui Hian, Gregory YH Lip Burden of atrial fibrillation and stroke focus on the Asia-Pacific region (20mins) David Quek (Malaysia) 20 mins S46-2 Treatment strategies for stroke prevention in atrial fibrillation: what do the guidelines say and are they adhered to? Dayi Hu (China) 20 mins S46-3 The patient perspective Deirdre Lane (United Kingdom) 15mins S46-4 A Call to Action Shinya Goto (Japan) 20mins Panel Discussion 15mins
S46-1
HOW TO SESSION 2
17:30 18:30 ARRHYTHMIA 3
HT2-1
Reading ECG with the masters Presenters: 1) Yoga Yuniadi (Indonesia) 2) Zahid Aslam Awan (Pakistan) 3) Anthony King (Philippines) 4) Thoranis Chantarat (Thailand) Panelist: 1) Balbir Singh (India) 2) Sirin Apiyasawat (Thailand) 3) C. Narasimhan (India) 4) Vincent Paul (Australia)
Ballroom 1, Level 3
S3-2
Central Aortic Blood Pressure Monitoring What is the Evidence? Bryan Williams (United Kingdom)
S3-3
Blood pressure variability: Its relevance to clinical practice Yukata Imai (Japan)
SYMPOSIUM 5
11:00 12:30 MYOCARDIAL ISCHAEMIA 1: UA-NSTEMI Chairpersons: Dr. WS Santharaj/ Dr. Lawrence Chan S5-1 Cardiac Biomarkers: State of the art Sidney Smith (US) S5-2 Risk stratification in UA-NSTEMI Jeyamalar (Malaysia) S5-3 Anti-platelet therapy in ACS TBC
SYMPOSIUM 8
14:00 15:30 CARDIAC REHABILITATION 1: KEEPING THE CARDIAC REHABILITATION AGENDA RELEVANT Chairpersons: Aizai Azan ( Mal ) / Antonio Sibulo ( Phi ) S8-1 Cardiac Rehabilitation As A Treatment Modality: What Is The Current Evidence? Leandro Bongosia (Philippines) S8-2 Exercise Testing and Prescription In Cardiac Rehabilitation: Clinical And Practical Considerations Visal Kantaratanakul (Thailand) S8-3 Revamping Weight Loss Management For Cardiovascular Health TBC
HOW TO SESSION 6
17:30 18:30 HYPERTENSION 6
Chairpersons:
HT6-1
HT6-2
Ballroom 2, Level 3
SYMPOSIUM 45
09:00 10:30 SPECIAL LECTURE 2 - REPERFUSION INJURY
Chairpersons: Dr. Waheed/ Dr. Ong Mei Ling S45-1 Case Presentation (Slow/No Reflow in ACS) Rosli (Malaysia) (15min) S45-2 A new decade in reperfusion therapy : Role of Cardiac Biomarkers Thach Nguyen (US) S45-3 Management of Ischemic / Reperfusion injury, Bench to Bed. Dong-Ju Choi (Korea) (45 min)
SYMPOSIUM 6
11:00 12:30 PREVENTIVE CARDIOLOGY 1: LIPIDOLOGY: LDL-C AND BEYOND Chairpersons: Khoo Kah Lin (MY) and and Eleanor A Lopes (Phil) S6-1 Targets for Dyslipidemia in Primary and Secondary Prevention and the Role of Hs-CRP Nathan Wong (USA) S6-2 Triglyceride-Lowering For Reduction of Residual Risk Paola Fioretto (Italy) S6-3 Options for Increasing HDL Sang-Hong Baek (Korea)
Opening remarks by chairperson Lecture by Prof. Dr. Hans-Henrik Parving Q&A Closing Remarks
SYMPOSIUM 9
14:00 15:30 VALVULAR HEART DISEASE 1: INFECTIVE ENDOCARDITIS
Chairpersons: Suggest maybe Rahal and Mr Paneer Selvam S9-1 Challenges in the Diagnosis of IE Rick Nishimura (USA) S9-2 Prophylaxis and Anti Microbial Therapy in IE Mario Panaligan (Philippines) S9-3 Indication for Surgery and Surgical Options Taweesak Chotivatanapong (Thailand) 16:00 17:30
MERCK SERONO SATELLITE SYMPOSIUM - INSIGHTS ON THE ESH GUIDELINE ON MANAGING HYPERTENSION
HOW TO SESSION 7
17:30 18:30 INTERVENTIONAL CARDIOLOGY 3
Chairpersons:
HT10-1
HT10-2
HT10-3
HT1-1
HT1-2
12:30 - 12:40 12:40 - 13:00 13:00 - 13:20 13:20 - 13:40 13:40 - 13:55 13:55 - 14:00
Introduction --Tan Sri Robaayah (Is newer always better ?) (10 mins) Stents, Stents and more Stents: Which DES is the safest in the market? (20mins) Biosorable polymer and New Alloys: Can they change the Treatment Algorithms ? (20mins) No environment is too challenging: Can We Choose the Right DES for a Particular Patient? A Case study (20 mins) Panelists discussion--- 15 mins Conclusion --5 mins
HOW TO SESSION 3
17:30 18:30 ENDOVASCULAR THERAPEUTICS 3
HT3-1
HT3-2
How To Ensure A Successful Peripheral Intervention: Useful Tips And Tricks Neil Strickman (US)
HT3-3
How To Deal With Peripheral Intervention Complications(15 Mins) Shaiful Azmi (MY)
Chairpersons:
HT4-1
HT4-2
Chairpersons:
HT10-1
Chairpersons:
P6-1
Coarctation in children: treatment options and outcome Satoshi Yasukochi (Japan) Stenting of coarctation: case selection and consideration in growing patients (15 min) Joseph De Giovanni (UK) Stenting of Coarctation: techniques and equipment (15 Min) Masood Sadiq (Pakistan)
PC2-2
PC2-3
PC2-4
Dealing with difficult lesions and complications (20 min) Shakeel A Qureshi (UK)
PC3-1
Spectrum of peripheral PA stenosis (15 min) Krishna Kumar (India) Branch pulmonary artery stenting: case selection, challenges and technical considerations (20 min) Neil Wilson (UK) Pulmonary artery stenting in the hybrid lab (15 min) Ziyad M. Hijazi (US)
PC3-2
PC3-3
PC3-4
Multiple peripheral stenosis: role of catheter intervention and outcome- (15 min) Joseph De Giovanni (UK)
PC4-1
Technical considerations and peri-procedure care in neonatal interventions (15 min) Jou-Kou Wang (Taipei) Radiofrequency valvotomy in PAIVS: case selection and technical consideration (15 min) Mazeni Alwi (Malaysia) Critical AS: surgery versus catheter intervention (20 min) Neil Wilson (UK) Hypoplastic left heart syndrome Outcome of the hybrid approach - (20 min) Ralf J Holzer (US) Aims: to elaborate on the outcome second stage (Glen and Norwood) following initial Hybrid in HLHS.
PC4-2
PC4-3
PC4-4
HOW TO SESSION 8
17:30 18:30 CARDIAC IMAGING 6: CARDIAC CT Chairpersons: Ong TK & ASEAN speaker (? Tan Swee Yaw)
HT8-1
Patient Selection and Preparation. Do We Still Need Beta Blockers? (12min) Manoefris Kasim (Indonesia) Appropriate use of Cardiac CT what do the latest guidelines say? (12 min) Ong Tiong Kiam (Malaysia)
HT8-2
HT8-3
Interesting Case Demo (25 min) Suren Thuraisingham / Chan Wai Ling / Dr Haifa (IJN) Dr Ahmad to confirmed
Chairpersons: S17-1 Advances in Medical Management of Acute Heart Failure Byung-Hee Oh (Korea) S17-2 Acute Heart Failure The Role of Mechanical Circulatory Support Mohamed Ezani Md. Taib (Malaysia) S17-3 Viral Infections in Heart Failure Akira Matsumori (Japan)
SYMPOSIUM 22
11:00 12:30 HEART FAILURE 5: ADVANCED HEART FAILURE
S22-1
S22-2
Optimal Medical Therapy For Advance Systolic Heart Failure Michel Komadja (Europe)
S22-3
S22-4
Long Term VAD Support and New Ventricular Assist Devices Mohamed Ezani Md. Taib (Malaysia)
SYMPOSIUM 27
14:00 15:30 MEET WITH THE EXPERTS 1
Chairpersons:
S27-1
SYMPOSIUM 32
16:00 17:30 VASCULAR DISEASE 1
S32-1
Understanding PVD: The Most Neglected Member of CVD Neil Strickman (USA)
S32-2
S32-3
HOW TO SESSION 12
17:30 18:30 PREVENTIVE CARDIOLOGY 7: HOW TO SET UP EFFECTIVE PREVENTIVE AND REHAB PROGRAMMES
HT12-1
How to Start A Cardiac Rehabilitation Service In Your Hospital (From Scratch!) Peter Ting (Singapore)
HT12-2
How to Set Up A Preventive Cardiology Programme In Your Hospital David Wood (UK)
S35-1
S35-2
Clinical Decision Trees in HCM: Risk of Sudden Death Zahid Aslam Awan (Pakistan)
S35-3
S35-4
SYMPOSIUM 24
11:00 12:30 GENERAL CARDIOLOGY 2
Chairpersons:
S24 -1
Evidence Based Medicine from Bench to Bedside (concentrating on pre-clinical and clinical studies) Alan Fong (Malaysia)
S24 -2
Evidence Based Medicine in population-based studies (concentrating on cardiovascular epidemiology) Tai Ee Shyong (Singapore)
S24 -3
Incorporating Evidence into Guidelines (the bigger picture) Ralph Brindis (USA)
SYMPOSIUM 26
14:00 15:30 JOINT SYMPOSIUM 2: APSC ACC Joint Symposium
Chairpersons:
S26-1
S26-2
The Latest on Treatment of CAD KIV Speaker TAVI Malaysia Perspective Rosli
S26-3
SYMPOSIUM 31
16:00 17:30 Chairpersons: SPECIAL LECTURE: CARDIOPULMONARY RESUSCITATION TODAY
S31-1
S31-2
S31-3
Evidences behind the major changes in ACLS Lim Swee Han (SG)
S31-4
HOW TO SESSION 11
17:30 18:30 CLINICAL CARDIOLOGY 1
HT11-1
HT11-2
S19-1
Critical Limb Ischaemia: From Claudication To Gangrene - Why Do We Keep Missing Them? Yoshioki Yokoi (Japan)
S19-2
Multidisciplinary Approach For Critical Limb Ischaemia: Is It Feasible? Paul Kao (Taiwan)
S19-3
SYMPOSIUM 20
11:00 12:30 JOINT SYMPOSIUM 1: AMERICAN SOCIETY OF PREVENTIVE CARDIOLOGY AT APSC - CHALLENGES AND OPPORTUNITY: OBESITY AND DIABETES IN ASIA
Chairpersons: DR Jeya: Prof Wan Mohd/Dr.Sidney Smith or Dr NIk Halmey: Chin Sze Piaw (MY) Hirosutgo Muetshima (JPN)
S20-1
Obesity, Diabetes and Cardiovascular Disease: Epidemiology and Guidelines for Management of Cardiometabolic Risks Nathan Wong (USA)
S20-2
The Changing Pattern of Cardiabesity in Asia Pacific: Indication and Prevention Juliana Chan (Hong Kong) Risk Assessment and Screening for Atherosclerosis in Metabolic Syndrome and Diabetes: Whats The Best Way? Rody Sy (Philippines)
S20-3
Opening Remarks and Introduction by Chairperson Razali Omar (Malaysia) A Paradigm Shift in Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation Latest Update Gregory Lip Discussion Lunch
SYMPOSIUM 28
14:00 15:30 CARDIAC SURGERY 1: NON-ISCHEMIC MITRAL REGURGITATION
Chairpersons:
S28-1
S28-2
S28-3
SYMPOSIUM 30
16:00 17:30 CARDIAC IMAGING 3: IMAGING IN RISK STRATIFICATION OF CHALLENGING PATIENTS
S30-1
Asymptomatic Diabetics And CAD: Should We Test And What Is The Best Test? Thomas Marwick (Australia)
S30-2
Asymptomatic Patients with High Coronary Calcium: What to Do Next? Samuel Wann (USA)
S30-3
Non Invasive Testing For CAD In The Physically Challenged Patient: What Is Available? Thomas Marwick (Australia)
HOW TO SESSION 9
17:30 18:30 ARRHYTHMIA 4
HT9-1
HT9-2
HT9-3
Ballroom 1, Level 3
Chairpersons:
P5-1 Translational Medicine-Applying The Evidence to Optimise Management of Hypertension Liu Li Sheng (China) P5-2 Updates in clinical practice guideline in treating hypertension Roberto Ferrari (Italy)
SYMPOSIUM 18
09:00 10:30 HYPERTENSION 3: END ORGAN DAMAGE IN HYPERTENSION
Chairpersons: Hypertensive Heart Disease Mechanisms and Treatment Options R Prabash Chand Manoria (India) S18-2 How Can We Best Preserve Kidney Function In Our Hypertensive Patients? Ghazali Ahmad (MY) S18-3 Hypertension And Dementia Park Jeong Bae (Korea)
S18-1
SYMPOSIUM 15
11:00 12:30 CARDIAC REHAB 2: CARDIAC REHABILITATION IN SPECIAL POPULATIONS
S15-1
Congestive Heart Failure Rehabilitation: Current Perspectives Tan Swee Yaw (Singapore)
S15-2
Physical Activity And Exercise For The Elderly Lydia Latiff (UMMC)
S15-3
Rehabilitation Considerations For Patients With Arrhythmias and Devices Yoichi Goto (Japan)
SYMPOSIUM 25
14:00 15:30 HYPERTENSION 4: MANAGEMENT OF HYPERTENSION
Chairpersons: Increasing Burden of Hypertension in the Asia-Pacific Region Defining the Challenges Trefor Morgan (AU) S25-2 Non Pharmacological Management of Hypertension Prof Djanggan Sargowo S25-3 Control of Hypertension in Developing Countries What Strategies May Work? Is Single Pill Combination the Way Forward? (Novartis) Azhari Rosman (Malaysia)
S25-1
SYMPOSIUM 33
16:00 17:30 CARDIAC REHAB 3: THE ART AND SCIENCE OF COMPLIANCE
S33-1
S33-2
Understanding Health Behaviour Changes. Helping Patients To Help Themselves Jack Lewin (US)
S33-3
Returning To Work: What Are the Issues? Tan Swee Yaw (Singapore)
HOW TO SESSION 13
17:30 18:30 SPECIAL TOPIC 3
Chairpersons:
HT 13-1
How to Write The Clinical Papers And Get It Publish Goh Pik Pin
Ballroom 2, Level 3
P4-1
P4-2
SYMPOSIUM 16
09:00 10:30 CLINICAL CARDIOLOGY 1: ACS - A NEW HORIZON IN THERAPY
Chairpersons:
S16-1
Are All ADP-Antagonist Antiplatelets the Same? Robaayah Zambahari The New Oral Anticoagulants in ACS Beyond Conventional Dual Antiplatelet Therapy Ken Kozuma
S16-2
S16-3
SYMPOSIUM 21
11:00 12:30 CLINICAL CARDIOLOGY 2: FRONTIERS IN STEMI
Chairpersons:
S21-1
Antiplatelets - Optimising Net Clinical Benefit Balance of Efficacy and Safety Fady Michel Turquieh (Lebanon) Primary PCI in STEMI Asian Pacific Perspective Tan Huay Cheem (Singapore)
S21-2
S21-3
SYMPOSIUM 29
14:00 15:30 PREVENTIVE CARDIOLOGY 3: ASYMPTOMATIC AND SUBCLINICAL CORONARY DISEASE
S29-1
Do Biomarkers And Screening For Subclinical Atherosclerosis Improve Cardiovascular Disease Risk Prediction? Nathan Wong (US)
S29-2
Integrating Data from Plaque Regression Studies into CV Prevention Choo Gim Hooi (MY)
S29-3
Anatomical Imaging vs. Functional Testing for Asymptomatic Coronary Disease-Which is Better? Tan Swee Yaw (Singapore)
SYMPOSIUM 34
16:00 17:30 JOINT SYMPOSIUM 3: APSC-WHF TOBACCO CONTROL: WHATS NEW AND SMOKING HOT?
Chairpersons: David Quek ( Mal ) / Kathryn Taubert (US) S34-1 What Do We Do About The Smoking Epidemic In Asia? Sidney Smith (US) S34-2 Current Experience From The EUROACTION -PLUS Study And Other Lessons Learnt From The UK David Wood (UK) S34-3 Current Treatment Options For Nicotine Dependence Mohamed Haniki Nik Mohamed S34-4 Smokeless Tobacco And Passive Smoking: What Are The Real Consequences Zarihah Zain
HOW TO SESSION 14
17:30 18:30 SPECIAL TOPIC 4
HT 14-1
Chairpersons: Datuk Paduka Dr. Santha/ Dr. Kathyrn Taubert WH1-1 Preeclampsia and Future Cardiovascular Disease Risk Nanette Wenger (US) WH1-2 Hypertension and Heart failure in Pregnancy Eleanor Lopez (Philippines) WH1-3 Peripartum Cardiomyopathy Ganesja M Harimurti (Ind)
11:00 12:30
Chairpersons: Dr. Dewi Ramasamy / Dr. Akira Matsumori WH2-1 Are there any physiological gender Differences in CVD? Nanette Wenger (US) WH2-2 Assessment of chest pains and Management of CAD in women Goh Ping Ping (Singapore) WH2-3 Prevention of Heart Disease in Women Kathryn Taubert (US)
14:00 15:30
Chairpersons: Dr Zanariah/Dr. Goh Ping Ping WH3-1 Hypertension, Diabetes and Dyslipidemia in Women : Is treatment different from Men? Ong Mei Ling (Malaysia) WH3-2 Calcium, Vit D deficiency and women's Health Zanariah Hussein (Malaysia) WH3-3 Population strategies to reduce CVD in Women Nanette Wenger (US)
16:00 17:30
Chairpersons: Dr Robayaah 1) Dr Eleanor A Lopez, President, Philippine Heart Association 2) Dr Anna Ulfah Rahajoe, Indonesia Heart Association 3) Dr Goh Ping Ping, Singapore
P9-1
Stem Cell therapy for ischemic heart disease Chin Sze Piaw (Malaysia)
P9-2
Gene and Stem Cell therapy in Heart Failure Sandeep Seth (India)
SYMPOSIUM 41
11:00 12:30 S41-1 MEET WITH THE EXPERTS 2 STABLE ANGINA Controversies in Management Case Based Approach Dato Rosli & Steven V. Manoukian (US)
Chairpersons: S38-1 SCD in Young Adults Asian Pacific Perspective Yash Lokhandwala (India) S38-2 CAD In The Young Adults Roberto Ferrari (Italy) S38-3 Prevention of SCD In The Young Adults Are We Doing Enough? Mohan Nair (India)
SYMPOSIUM 42
11:00 12:30 GENERAL CARDIOLOGY 3: PULMONARY HYPERTENSION
Chairpersons: Dr Ashari Yunus/Dr Kevin Joseph Pulmonary Hypertension New Classification and Definition Hyong Nick KIM (US) S42-2 Update on Pathogenesis of Pulmonary Arterial Hypertension David Chew S42-3 Screening and Diagnosis of PAH: Do We Really Need RHC James Yip (Singapore) S42-4 Management of Pulmonary Hypertension Hyong Nick KIM (US)
S42-1
Chairpersons: P8-1 New Anti-Coagulants: Will we say good bye to Warfarin? Gregory Lip (UK) P8-2 Appendage closure devices Razali (Malaysia)
SYMPOSIUM 37
09:00 10:30 ENDOVASCULAR THERAPEUTICS 2: SUPRA AORTIC ARTERY SYMPOSIUM
S37-1 S37-2
Intervention for Subclavian Artery Stenosis; How I do it ? Yoshioki Yokoi (Japan) Case presentation Plumbing For Carotid Artery Stenosis: Can We Stent All Lesions? Neil Strickman (US) Case presentation Carotid Artery Stenosis: A Surgeons Viewpoint Hanafiah Harunarashid (MY) 2 Case Presentations (10 min Each) 3 Foreign Delegates To Present Cases
S37-3
SYMPOSIUM 40
11:00 - 12:30 CARDIAC IMAGING 4: CARDIACT CT-STILL HOT, NEW & CONTROVERSIAL
S40-1
S40-2
S40-3
Ballroom 1, Level 3
Chairpersons: Pre-Hypertension Is There Enough Evidence to Treat? TBC S36-2 Hypertension at The Extreme Of Age How Aggressive Do We Have To Be Bryan Williams (UK) S36-3 Emerging Strategies for Management of CV risk Factors in Hypertension Gary Jennings (Australia)
S36-1
SYMPOSIUM 43
11:00 12:30 HEART FAILURE AND ATRIAL FIBRILLATION
Chairpersons:
S43-1
S43-2.
S43-3
Ballroom 2, Level 3
P7-1
Challenges and Opportunity for Preventive Cardiology: Lessons from Europe David Wood (UK)
P7-2
Challenges and Opportunity for Preventive Cardiology: Asia Pacific Perspective David Quek (MY)
SYMPOSIUM 39
09:00 10:30 JOINT SYMPOSIUM 5: EAPCR AT APSC 2011
Chairpersons: Dr Jeya: Dr. Roberta Ferrari/ Dr. Sim Kui Hian or Dr Nik Halmey: Liew Houng Bang (MY) /Eugene Reyes (Phil)
S39-1
EUROACTION: A Benchmark For Modern Preventive Cardiology Care David Wood (UK)
S39-2
Spoilt For Choice! CV Risk Scores And Applicability To The Asia-Pacific Population Tai E Shiong (Singapore) The Polypill: Establishing Its Role In Preventive Cardiology Sidney Smith (US)
S39-3
SYMPOSIUM 44
11:00 12:30 PREVENTIVE CARDIOLOGY 5: REAL WORLD ISSUES IN CARDIOVASCULAR DISEASE PREVENTION
Chairpersons: Alan Fong (MY) and Peter Ting (Sing) S44-1 For Asian Palates: Challenges In Healthy Eating Mary Easaw (MY) S44-2 Salt Reduction And Cardiovascular Disease: From Evidence To Worldwide Implementation Trefor Morgan (Australia) S44-3 Vitamins and Supplements: What Works (And What Doesnt!) Eugene Reyes (Philippines)